Press releases
MGC Pharmaceuticals Enters Partnership With Sciensus Rare For The Distribution Of CannEpil And CogniCann In The EU And UK
· MGC EXECUTES supply and distribution agreement with international pharmaceuticals company Sciensus Rare. · Sciensus Rare is an established international pharmaceutical services company, specialising in the provision of rare disease medicines through a network of decentralised clinical trials, early access programs and licensed distribution programs. · Sciensus Rare appointed the exclusive distributor of MGC Pharma’s CannEpil® and CogniCann®…